The roles of genetic factors in uveitis and their clinical significance

Retina

Volumn 34, Issue 1, 2014, Pages 1-11

  Yang, Ming Ming ^a,b   Lai, Timothy Y Y ^a   Luk, Fiona O J ^a   Pang, Chi Pui ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Chemokine; Complement system; Genetics; HLA; Inflammation; Polymorphisms; Uveitis

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; HLA ANTIGEN; HLA B27 ANTIGEN; INTERLEUKIN DERIVATIVE; TUMOR NECROSIS FACTOR;

CLINICAL FEATURE; COMPLEMENT SYSTEM; DISEASE COURSE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETICS; HEREDITY; HLA SYSTEM; HUMAN; INTERMEDIATE UVEITIS; IRIDOCYCLITIS; OXIDATION; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; UVEITIS;

CHEMOKINES; COMPLEMENT SYSTEM PROTEINS; HLA ANTIGENS; HUMANS; MOLECULAR BIOLOGY; UVEITIS;

EID: 84891840160     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31829f7415     Document Type: Review

References (132)

1. Suttorp-Schulten MS, Rothova A. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol 1996;80:844-848.
2. Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005;140:509-516.
3. Nussenblatt RB. The natural history of uveitis. Int Ophthalmol 1990;14:303-308.
4. Caspi RR. Immune mechanisms in uveitis. Springer Semin Immunopathol 1999;21:113-124.
5. Martin TM, Rosenbaum JT. Genetics in uveitis. Int Ophthalmol Clin 2005;45:15-30.
6. Nussenblatt RB, Mittal KK, Ryan S, et al. Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen. Am J Ophthalmol 1982; 94:147-158.
7. Brewerton DA, Caffrey M, Nicholls A, et al. Acute anterior uveitis and HL-A 27. Lancet 1973;302:994-996.
8. Ohno S, Ohguchi M, Hirose S, et al. Close association of HLA-Bw51 with Behcet's disease. Arch Ophthalmol 1982; 100:1455-1458.
9. Mizuki N, Ota M, Katsuyama Y, et al. HLA-B51 allele analysis by the PCR-SBT method and a strong association of HLA-B5101 with Japanese patients with Behcet's disease. Tissue Antigens 2001;58:181-184.
10. Oruc S, Duffy BF, Mohanakumar T, Kaplan HJ. The association of HLA class II with pars planitis. Am J Ophthalmol 2001;131:657-659.
11. Alaez C, del Pilar Mora M, Arellanes L, et al. Strong association of HLA class II sequences in Mexicans with Vogt-Koyanagi-Harada's disease. Hum Immunol 1999;60:875-882.
12. Islam SM, Numaga J, Fujino Y, et al. HLA class II genes in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 1994;35:3890-3896.
13. Levinson RD, Park MS, Rikkers SM, et al. Strong associations between specific HLA-DQ and HLA-DR alleles and the tubulointerstitial nephritis and uveitis syndrome. Invest Ophthalmol Vis Sci 2003;44:653-657.
14. Brewerton DA, Caffrey M, Nicholls A, et al. Reiter's disease and HL-A 27. Lancet 1973;302:996-998.
15. Schlosstein L, Terasaki PI, Bluestone R, Pearson CM. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 1973;288:704-706.
16. Tripodis N, Mason R, Humphray SJ, et al. Physical map of human 6p21.2-6p21.3: region flanking the centromeric end of the major histocompatibility complex. Genome Res 1998;8: 631-643.
17. Klein J, Sato A. The HLA system. Second of two parts. N Engl J Med 2000;343:782-786.
18. Caffrey MF, James DC. Human lymphocyte antigen association in ankylosing spondylitis. Nature 1973;242:121.
19. Chang JH, McCluskey PJ, Wakefield D. Acute anterior uveitis and HLA-B27. Surv Ophthalmol 2005;50:364-388.
20. Lan C, Tam PO, Chiang SW, et al. Manganese superoxide dismutase and chemokine genes polymorphisms in Chinese patients with anterior uveitis. Invest Ophthalmol Vis Sci 2009;50:5596-5600.
21. Wakefield D, Montanaro A, McCluskey P. Acute anterior uveitis and HLA-B27. Surv Ophthalmol 1991;36:223-232.
22. Wakefield D, Wright J, Penny R. HLA antigens in uveitis. Hum Immunol 1983;7:89-93.
23. van der Linden S, Valkenburg H, Cats A. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals: a family and population study. Br J Rheumatol 1983; 22:18-19.
24. Rosenbaum JT, Davey MP. Time for a gut check: evidence for the hypothesis that HLA-B27 predisposes to ankylosing spondylitis by altering the microbiome. Arthritis Rheum 2011;63:3195-3198.
25. Ebringer R. Acute anterior uveitis and faecal carriage of gramnegative bacteria. Br J Rheumatol 1988;27(Suppl 2):42-45.
26. Brezin AP, Monnet D, Cohen JH, Levinson RD. HLA-A29 and birdshot chorioretinopathy. Ocul Immunol Inflamm 2011; 19:397-400.
27. Gaudio PA, Kaye DB, Crawford JB. Histopathology of birdshot retinochoroidopathy. Br J Ophthalmol 2002;86:1439-1441.
28. Shah KH, Levinson RD, Yu F, et al. Birdshot chorioretinopathy. Surv Ophthalmol 2005;50:519-541.
29. Raja SC, Jabs DA, Dunn JP, et al. Pars planitis: clinical features and class II HLA associations. Ophthalmology 1999;106:594-599.
30. Ballerini C, Guerini FR, Rombola G, et al. HLA-multiple sclerosis association in continental Italy and correlation with disease prevalence in Europe. J Neuroimmunol 2004;150: 178-185.
31. Mizuki N, Ota M, Yabuki K, et al. Localization of the pathogenic gene of Behcet's disease by microsatellite analysis of three different populations. Invest Ophthalmol Vis Sci 2000; 41:3702-3708.
32. Yabuki K, Inoko H, Ohno S. HLA testing in patients with uveitis. Int Ophthalmol Clin 2000;40:19-35.
33. Brown MA, Kennedy LG, MacGregor AJ, et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 1997;40:1823-1828.
34. Rubin LA, Amos CI, Wade JA, et al. Investigating the genetic basis for ankylosing spondylitis. Linkage studies with the major histocompatibility complex region. Arthritis Rheum 1994;37:1212-1220.
35. Linssen A, Rothova A, Valkenburg HA, et al. The lifetime cumulative incidence of acute anterior uveitis in a normal population and its relation to ankylosing spondylitis and histocompatibility antigen HLA-B27. Invest Ophthalmol Vis Sci 1991;32:2568-2578.
36. Lacomba MS, Martin CM, Chamond RR, et al. Aqueous and serum interferon gamma, interleukin (IL) 2, IL-4, and IL-10 in patients with uveitis. Arch Ophthalmol 2000;118: 768-772.
37. Liu L, Xu Y, Wang J, Li H. Upregulated IL-21 and IL-21 receptor expression is involved in experimental autoimmune uveitis (EAU). Mol Vis 2009;15:2938-2944.
38. Nussenblatt RB, Thompson DJ, Li Z, et al. Humanized antiinterleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration. J Autoimmun 2003;21:283-293.
39. Lee RW, Schewitz LP, Nicholson LB, et al. Steroid refractory CD4+ T cells in patients with sight-threatening uveitis. Invest Ophthalmol Vis Sci 2009;50:4273-4278.
40. Karasneh J, Hajeer AH, Barrett J, et al. Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behcet's disease. Rheumatology (Oxford) 2003;42:860-864.
41. Cordeiro CA, Moreira PR, Costa GC, et al. Interleukin-1 gene polymorphisms and toxoplasmic retinochoroiditis. Mol Vis 2008;14:1845-1849.
42. Hamzaoui K, Hamza M, Ayed K. Production of TNF-alpha and IL-1 in active Behcet's disease. J Rheumatol 1990;17: 1428-1429.
43. Coskun M, Bacanli A, Sallakci N, et al. Specific interleukin-1 gene polymorphisms in Turkish patients with Behcet's disease. Exp Dermatol 2005;14:124-129.
44. Yosipovitch G, Shohat B, Bshara J, et al. Elevated serum interleukin 1 receptors and interleukin 1B in patients with Behcet's disease: correlations with disease activity and severity. Isr J Med Sci 1995;31:345-348.
45. Menezo V, Bond SK, Towler HM, et al. Cytokine gene polymorphisms involved in chronicity and complications of anterior uveitis. Cytokine 2006;35:200-206.
46. Shahram F, Nikoopour E, Rezaei N, et al. Association of interleukin-2, interleukin-4 and transforming growth factorbeta gene polymorphisms with Behcet's disease. Clin Exp Rheumatol 2011;29:S28-S31.
47. Charteris DG, Lightman SL. Comparison of the expression of interferon gamma, IL2, IL4, and lymphotoxin mRNA in experimental autoimmune uveoretinitis. Br J Ophthalmol 1994;78:786-790.
48. Lindner E, Weger M, Steinwender G, et al. IL2RA gene polymorphism rs2104286 A>G seen in multiple sclerosis is associated with intermediate uveitis: possible parallel pathways? Invest Ophthalmol Vis Sci 2011;52:8295-8299.
49. Torun N, Callizo J, Orlic N, et al. Serum cytokine receptor levels in noninfectious uveitis. Ophthalmic Res 2005;37:112-116.
50. Chang HK, Jang WC, Park SB, et al. Association between interleukin 6 gene polymorphisms and Behcet's disease in Korean people. Ann Rheum Dis 2005;64:339-340.
51. Ohta K, Wiggert B, Yamagami S, et al. Analysis of immunomodulatory activities of aqueous humor from eyes of mice with experimental autoimmune uveitis. J Immunol 2000;164:1185-1192.
52. Cordeiro CA, Moreira PR, Andrade MS, et al. Interleukin-10 gene polymorphism (-1082G/A) is associated with toxoplasmic retinochoroiditis. Invest Ophthalmol Vis Sci 2008;49:1979-1982.
53. Atan D, Turner SJ, Kilmartin DJ, et al. Cytokine gene polymorphism in sympathetic ophthalmia. Invest Ophthalmol Vis Sci 2005;46:4245-4250.
54. Xavier JM, Shahram F, Davatchi F, et al. Association study of IL10 and IL23R-IL12RB2 in Iranian patients with Behcet's disease. Arthritis Rheum 2012;64:2761-2772.
55. Broderick CA, Smith AJ, Balaggan KS, et al. Local administration of an adeno-associated viral vector expressing IL-10 reduces monocyte infiltration and subsequent photoreceptor damage during experimental autoimmune uveitis. Mol Ther 2005;12:369-373.
56. Ekinci NS, Alpsoy E, Karakas AA, et al. IL-17A has an important role in the acute attacks of Behcet's disease. J Invest Dermatol 2010;130:2136-2138.
57. Jang WC, Nam YH, Ahn YC, et al. Interleukin-17F gene polymorphisms in Korean patients with Behcet's disease. Rheumatol Int 2008;29:173-178.
58. Shu Q, Yang P, Hou S, et al. Interleukin-17 gene polymorphism is associated with Vogt-Koyanagi-Harada syndrome but not with Behcet's disease in a Chinese Han population. Hum Immunol 2010;71:988-991.
59. Yang MM, Lai TY, Tam PO, et al. Complement factor H and interleukin gene polymorphisms in patients with non-infectious intermediate and posterior uveitis. Mol Vis 2012;18:1865-1872.
60. Li F, Yang P, Liu X, et al. Upregulation of interleukin 21 and promotion of interleukin 17 production in chronic or recurrent Vogt-Koyanagi-Harada disease. Arch Ophthalmol 2010;128: 1449-1454.
61. Jiang Z, Yang P, Hou S, et al. IL-23R gene confers susceptibility to Behcet's disease in a Chinese Han population. Ann Rheum Dis 2010;69:1325-1328.
62. Zhou H, Jiang Z, Yang P, et al. Polymorphisms of IL23R and Fuchs' syndrome in a Chinese Han population. Mol Vis 2010; 16:2585-2589.
63. Jiang Z, Yang P, Hou S, et al. Polymorphisms of IL23R and Vogt-Koyanagi-Harada syndrome in a Chinese Han population. Hum Immunol 2010;71:414-417.
64. Ozcimen AA, Dilek K, Bingol U, et al. IL-1 cluster gene polymorphisms in Turkish patients with Behcet's disease. Int J Immunogenet 2011;38:295-301.
65. Luger D, Silver PB, Tang J, et al. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med 2008;205:799-810.
66. Botsios C, Sfriso P, Furlan A, et al. Resistant Behcet disease responsive to anakinra. Ann Intern Med 2008;149:284-286.
67. Stanford MR, Vaughan RW, Kondeatis E, et al. Are cytokine gene polymorphisms associated with outcome in patients with idiopathic intermediate uveitis in the United Kingdom? Br J Ophthalmol 2005;89:1013-1016.
68. Wallace GR, Kondeatis E, Vaughan RW, et al. IL-10 genotype analysis in patients with Behcet's disease. Hum Immunol 2007;68:122-127.
69. Remmers EF, Cosan F, Kirino Y, et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease. Nat Genet 2010;42:698-702.
70. Barrett JC, Clayton DG, Concannon P, et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009;41:703-707.
71. Todd JA, Walker NM, Cooper JD, et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007;39:857-864.
72. Zhernakova A, Alizadeh BZ, Bevova M, et al. Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases. Am J Hum Genet 2007;81: 1284-1288.
73. Li Z, Liu B, Maminishkis A, et al. Gene expression profiling in autoimmune noninfectious uveitis disease. J Immunol 2008;181:5147-5157.
74. Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001;344: 907-916.
75. Evereklioglu C, Er H, Turkoz Y, Cekmen M. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behcet's disease. Mediators Inflamm 2002;11:87-93.
76. Van Deventer SJ. Tumour necrosis factor and Crohn's disease. Gut 1997;40:443-448.
77. Sfikakis PP, Markomichelakis N, Alpsoy E, et al. Anti-TNF therapy in the management of Behcet's disease-review and basis for recommendations. Rheumatology (Oxford) 2007;46: 736-741.
78. Lee EB, Kim JY, Lee YJ, et al. TNF and TNF receptor polymorphisms in Korean Behcet's disease patients. Hum Immunol 2003;64:614-620.
79. Seitz M, Wirthmuller U, Moller B, Villiger PM. The -308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNF-alpha-blockers in rheumatoid arthritis and spondyloarthritis patients. Rheumatology (Oxford) 2007;46:93-96.
80. Sullivan KE, Wooten C, Schmeckpeper BJ, et al. A promoter polymorphism of tumor necrosis factor alpha associated with systemic lupus erythematosus in African-Americans. Arthritis Rheum 1997;40:2207-2211.
81. Tolusso B, Fabris M, Caporali R, et al. -238 and +489 TNF-alpha along with TNF-RII gene polymorphisms associate with the diffuse phenotype in patients with systemic sclerosis. Immunol Lett 2005;96:103-108.
82. Vargas-Alarcon G, Casasola-Vargas J, Rodriguez-Perez JM, et al. Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with spondyloarthritis. Hum Immunol 2006; 67:826-832.
83. Kuo NW, Lympany PA, Menezo V, et al. TNF-857T, a genetic risk marker for acute anterior uveitis. Invest Ophthalmol Vis Sci 2005;46:1565-1571.
84. Touma Z, Farra C, Hamdan A, et al. TNF polymorphisms in patients with Behcet disease: a meta-analysis. Arch Med Res 2010;41:142-146.
85. Deghaide NH, Rodrigues Mde L, Castelli EC, et al. Tumor necrosis factor region polymorphisms are associated with AIDS and with cytomegalovirus retinitis. AIDS 2009;23: 1641-1647.
86. Adamus G, Manczak M, Machnicki M. Expression of CC chemokines and their receptors in the eye in autoimmune anterior uveitis associated with EAE. Invest Ophthalmol Vis Sci 2001;42:2894-2903.
87. Murphy PM. The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol 1994;12:593-633.
88. Crane IJ, Kuppner MC, McKillop-Smith S, et al. Cytokine regulation of RANTES production by human retinal pigment epithelial cells. Cell Immunol 1998;184:37-44.
89. Crane IJ, McKillop-Smith S, Wallace CA, et al. Expression of the chemokines MIP-1alpha, MCP-1, and RANTES in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci 2001; 42:1547-1552.
90. Fang IM, Yang CH, Lin CP, et al. Expression of chemokine and receptors in Lewis rats with experimental autoimmune anterior uveitis. Exp Eye Res 2004;78:1043-1055.
91. Verma MJ, Lloyd A, Rager H, et al. Chemokines in acute anterior uveitis. Curr Eye Res 1997;16:1202-1208.
92. Kim SK, Jang WC, Ahn YC, et al. Promoter -2518 single nucleotide polymorphism of monocyte chemoattractant protein-1 is associated with clinical severity in Behcet's disease. Inflamm Res 2012;61:541-545.
93. Wegscheider BJ, Weger M, Renner W, et al. Role of the CCL2/MCP-1 -2518A>G gene polymorphism in HLA-B27 associated uveitis. Mol Vis 2005;11:896-900.
94. Yeo TK, Ahad MA, Kuo NW, et al. Chemokine gene polymorphisms in idiopathic anterior uveitis. Cytokine 2006;35:29-35.
95. Chen Y, Vaughan RW, Kondeatis E, et al. Chemokine gene polymorphisms associate with gender in patients with uveitis. Tissue Antigens 2004;63:41-45.
96. Ahad MA, Missotten T, Abdallah A, et al. Polymorphisms of chemokine and chemokine receptor genes in idiopathic immune-mediated posterior segment uveitis. Mol Vis 2007; 13:388-396.
97. Mojtahedi Z, Ahmadi SB, Razmkhah M, et al. Association of chemokine receptor 5 (CCR5) delta32 mutation with Behcet's disease is dependent on gender in Iranian patients. Clin Exp Rheumatol 2006;24:S91-S94.
98. Wallace GR, Vaughan RW, Kondeatis E, et al. A CX3CR1 genotype associated with retinal vasculitis in patients in the United Kingdom. Invest Ophthalmol Vis Sci 2006;47: 2966-2970.
99. Cho ML, Kim JY, Ko HJ, et al. The MCP-1 promoter -2518 polymorphism in Behcet's disease: correlation between allele types, MCP-1 production and clinical symptoms among Korean patients. Autoimmunity 2004;37:77-80.
100. Yang MM, Lai TY, Tam PO, et al. CFH 184G as a genetic risk marker for anterior uveitis in Chinese females. Mol Vis 2011;17:2655-2664.
101. Walport MJ. Complement. First of two parts. N Engl J Med 2001;344:1058-1066.
102. Walport MJ. Complement. Second of two parts. N Engl J Med 2001;344:1140-1144.
103. Jha P, Bora PS, Bora NS. The role of complement system in ocular diseases including uveitis and macular degeneration. Mol Immunol 2007;44:3901-3908.
104. Read RW, Szalai AJ, Vogt SD, et al. Genetic deficiency of C3 as well as CNS-targeted expression of the complement inhibitor sCrry ameliorates experimental autoimmune uveoretinitis. Exp Eye Res 2006;82:389-394.
105. Wakefield D, Buckley R, Golding J, et al. Association of complement allotype C4B2 with anterior uveitis. Hum Immunol 1988;21:233-237.
106. Ferrara DC, Merriam JE, Freund KB, et al. Analysis of major alleles associated with age-related macular degeneration in patients with multifocal choroiditis: strong association with complement factor H. Arch Ophthalmol 2008;126:1562-1566.
107. Yang MM, Lai TY, Tam PO, et al. Association of C2 and CFB polymorphisms with anterior uveitis. Invest Ophthalmol Vis Sci 2012;53:4969-4974.
108. Miceli-Richard C, Lesage S, Rybojad M, et al. CARD15 mutations in Blau syndrome. Nat Genet 2001;29:19-20.
109. Xiang H, Zhang T, Chen M, et al. NOD2/CARD15 gene mutation identified in a Chinese family with Blau syndrome. Mol Vis 2012;18:617-623.
110. Boiardi L, Salvarani C, Casali B, et al. Intercellular adhesion molecule-1 gene polymorphisms in Behcet's disease. J Rheumatol 2001;28:1283-1287.
111. Cimino L, Boiardi L, Aldigeri R, et al. G/R 241 polymorphism of intercellular adhesion molecule 1 (ICAM-1) is associated with Fuchs uveitis. Invest Ophthalmol Vis Sci 2010;51: 4447-4450.
112. Kamoun M, Ben Dhifallah I, Karray E, et al. Association of small ubiquitin-like modifier 4 (SUMO4) polymorphisms in a Tunisian population with Behcet's disease. Clin Exp Rheumatol 2010;28:S45-S49.
113. Ozkul Y, Evereklioglu C, Borlu M, et al. 5,10-Methylenetetrahydrofolate reductase C677T gene polymorphism in Behcet's patients with or without ocular involvement. Br J Ophthalmol 2005;89:1634-1637.
114. Nakao K, Isashiki Y, Sonoda S, et al. Nitric oxide synthase and superoxide dismutase gene polymorphisms in Behcet disease. Arch Ophthalmol 2007;125:246-251.
115. Ahmad T, Zhang L, Gogus F, et al. CARD15 polymorphisms in Behcet's disease. Scand J Rheumatol 2005;34:233-237.
116. Baruch Y, Dagan E, Rosner I, et al. MEFV, TNFRSF1A and CARD15 mutation analysis in Behcet's disease. Clin Exp Rheumatol 2011;29:S24-S27.
117. Uyar FA, Saruhan-Direskeneli G, Gul A. Common Crohn's disease-predisposing variants of the CARD15/NOD2 gene are not associated with Behcet's disease in Turkey. Clin Exp Rheumatol 2004;22:S50-S52.
118. Ben Dhifallah I, Karray EF, Sassi F, Hamzaoui K. Intercellular adhesion molecule 1 K469E gene polymorphism is associated with presence of skin lesions in Tunisian Behcet's disease patients. Tissue Antigens 2010;75:74-78.
119. Chmaisse HN, Fakhoury HA, Salti NN, Makki RF. The ICAM-1 469 T/C gene polymorphism but not 241 G/A is associated with Behcets disease in the Lebanese population. Saudi Med J 2006;27:604-607.
120. Hou S, Yang P, Du L, et al. SUMO4 gene polymorphisms in Chinese Han patients with Behcet's disease. Clin Immunol 2008;129:170-175.
121. Esmaeili M, Bonyadi M, Khabbazi A, et al. Common MEFV mutations in Iranian Azeri Turkish patients with Behcet's disease. Scand J Rheumatol 2011;40:383-386.
122. Atzeni F, Boiardi L, Nicoli D, et al. PLA1/A2 polymorphism of the platelet glycoprotein receptors IIIA in Behcet's disease. Clin Exp Rheumatol 2011;29:S38-S43.
123. Hu K, Hou S, Jiang Z, et al. JAK2 and STAT3 polymorphisms in a Han Chinese population with Behcet's disease. Invest Ophthalmol Vis Sci 2012;53:538-541.
124. Chen F, Hou S, Jiang Z, et al. CD40 gene polymorphisms confer risk of Behcet's disease but not of Vogt-Koyanagi-Harada syndrome in a Han Chinese population. Rheumatology (Oxford) 2012;51:47-51.
125. Hung YH, Wu CC, Ou TT, et al. Ikappa Balpha promoter polymorphisms in patients with Behcet's disease. Dis Markers 2010;28:55-62.
126. Du L, Yang P, Hou S, et al. Association of the CTLA-4 gene with Vogt-Koyanagi-Harada syndrome. Clin Immunol 2008;127:43-48.
127. Horie Y, Meguro A, Ota M, et al. Association of TLR4 polymorphisms with Behcet's disease in a Korean population. Rheumatology (Oxford) 2009;48:638-642.
128. Li K, Zhao M, Hou S, et al. Association between polymorphisms of FCRL3, a non-HLA gene, and Behcet's disease in a Chinese population with ophthalmic manifestations. Mol Vis 2008;14:2136-2142.
129. Cosan F, Oku B, Cakiris A, et al. No association of the TLR2 gene Arg753Gln polymorphism with rheumatic heart disease and Behcet's disease. Clin Rheumatol 2009;28: 1385-1388.
130. Horie Y, Kitaichi N, Katsuyama Y, et al. Evaluation of PTPN22 polymorphisms and Vogt-Koyanagi-Harada disease in Japanese patients. Mol Vis 2009;15:1115-1119.
131. Kara N, Senturk N, Gunes SO, et al. Lack of evidence for association between endothelial nitric oxide synthase gene polymorphism (glu298asp) with Behcet's disease in the Turkish population. Arch Dermatol Res 2006;297:468-471.
132. Meng Q, Guo H, Hou S, et al. Lack of an association of PD-1 and its ligand genes with Behcet's disease in a Chinese Han population. PLoS One 2011;6:e25345.